Chiasma, Inc. (CHMA) Financial Statements (2024 and earlier)

Company Profile

Business Address 140 KENDRICK STREET
NEEDHAM, MA 02494
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:15,46272,84052,19479,30092,40019,665
Cash and cash equivalents15,46272,84052,19442,55527,85519,665
Other undisclosed cash, cash equivalents, and short-term investments    36,74564,545 
Receivables538179    
Inventory, net of allowances, customer advances and progress billings10,9558,942    
Inventory10,9558,942    
Other undisclosed current assets126,40389,30018,6344,8393,85686,017
Total current assets:153,358171,26170,82884,13996,256105,682
Noncurrent Assets
Operating lease, right-of-use asset9851,1181,220   
Property, plant and equipment534581617590334209
Other noncurrent assets1,8832,4192,5211,9932,236992
Other undisclosed noncurrent assets19,57819,18218,780   
Total noncurrent assets:22,98023,30023,1382,5832,5701,201
TOTAL ASSETS:176,338194,56193,96686,72298,826106,883
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16,09817,42415,22712,68810,8299,294
Accounts payable4,2407,1497,0795,4503,2532,737
Accrued liabilities11,85810,2758,1487,2387,5766,557
Other liabilities633722716716546204
Total current liabilities:16,73118,14615,94313,40411,3759,498
Noncurrent Liabilities
Long-term debt and lease obligation:4806457859381,03681
Liabilities, other than long-term debt, including:4,2742,5481,444   
Operating lease, liability4806457859381,03681
Other undisclosed liabilities, other than long-term debt4,2742,5481,444   
Other undisclosed noncurrent liabilities63,06862,88423,816637646564
Total noncurrent liabilities:67,82266,07726,0451,5751,682645
Total liabilities:84,55384,22341,98814,97913,05710,143
Equity
Equity, attributable to parent91,785110,33851,97871,74385,76996,740
Common stock578578423423421420
Additional paid in capital438,920437,659360,977359,637358,245357,158
Accumulated other comprehensive income  62633749
Accumulated deficit(347,713)(327,905)(309,448)(288,320)(272,934)(260,887)
Total equity:91,785110,33851,97871,74385,76996,740
TOTAL LIABILITIES AND EQUITY:176,338194,56193,96686,72298,826106,883

Income Statement (P&L) ($ in thousands)

3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
Revenues964142  64 
Cost of revenue
(Cost of Goods and Services Sold)
(58)(3)    
Gross profit:906139    
Operating expenses(18,079)(17,571)(20,337)(15,707)(12,266)(8,226)
Operating loss:(17,173)(17,432)(20,337)(15,707)(12,266)(8,226)
Nonoperating income
(Other Nonoperating income)
    398469549
Interest and debt expense(2,839)(2,126)(907)   
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 626   (19) 
Loss from continuing operations before equity method investments, income taxes:(19,386)(19,558)(21,244)(15,309)(11,816)(7,677)
Other undisclosed income (loss) from continuing operations before income taxes(448)1,122128 19 
Loss from continuing operations before income taxes:(19,834)(18,436)(21,116)(15,309)(11,797)(7,677)
Income tax expense (benefit)26(21)(12)(77)(250)(6)
Loss from continuing operations:(19,808)(18,457)(21,128)(15,386)(12,047)(7,683)
Loss before gain (loss) on sale of properties:(19,808)(18,457)(21,128)(15,386)(12,047)(7,683)
Net loss available to common stockholders, diluted:(19,808)(18,457)(21,128)(15,386)(12,047)(7,683)

Comprehensive Income ($ in thousands)

3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
Net loss:(19,808)(18,457)(21,128)(15,386)(12,047)(7,683)
Other comprehensive income (loss) (6)(20)23(34)(12)(3)
Comprehensive loss, net of tax, attributable to parent:(19,814)(18,477)(21,105)(15,420)(12,059)(7,686)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: